Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
CMS grants NTAP for RECELL, adding up to $4,875 reimbursement for non-burn acute wounds, easing hospital costs and expanding patient access.
 - 
                            
Avita revealed a six-month backlog of unpaid Recell claims, hurting demand. Shares fell $1.13, or 21%, from $5.38 on Aug 7 to $4.25 on Aug 8, 2025.
 - 
                            
Avita stock dropped 21% after Q2 2025 results revealed CMS pricing delays caused a six-month backlog of unpaid Recell claims.
 - 
                            
AVITA Medical has received the CE Mark for RECELL GO. This mark enables AVITA to begin commercializing RECELL GO across Europe.
 - 
                            
Nashville, Tenn. and Gettysburg, Pa., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Qualifacts, a leading provider of electronic health record (EHR) and data solutions for behavioral health and human services...
 - 
                            
AVITA Medical appoints Dr. Michael Tarnoff to Board. Cary Vance becomes Board Chair, replacing Lou Panaccio. Strengthens acute wound care focus
 - 
                            
AVITA Medical today reported second-quarter commercial revenue of $15.1 million, reflecting growth of over 29% over the same period in the prior year.
 - 
                            
AVITA Medical to present at JP Morgan's Annual Healthcare Conference in San Francisco on Thursday, January 11, 2024.
 - 
                            
AVITA Medical to host investor webinar briefing on December 5, 2023, at 2:00 p.m. PST. Register at https://rebrand.ly/Dec2023webinar
 - 
                            
AVITA Medical announced it has entered into a distribution agreement with PolyMedics Innovations, to strategically expand its global presence to Europe.